{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:25:22Z","timestamp":1760016322938},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1985,6,1]],"date-time":"1985-06-01T00:00:00Z","timestamp":486432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1985,6,1]],"date-time":"1985-06-01T00:00:00Z","timestamp":486432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Oncol. & Tumor Pharmacother."],"published-print":{"date-parts":[[1985,6]]},"DOI":"10.1007\/bf02934855","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T18:21:13Z","timestamp":1631902873000},"page":"99-102","source":"Crossref","is-referenced-by-count":4,"title":["Methotrexate-vindesine association in leukemia: Pharmacokinetic study"],"prefix":"10.1007","volume":"2","author":[{"given":"N.","family":"Tubiana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Lena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Barbet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Maraninchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sainty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sebahoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Gastaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Carcassonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02934855_CR1","first-page":"232","volume":"16","author":"A I Freeman","year":"1975","unstructured":"Freeman A I, Wang J J, Sinks L F: High dose MTX in acute lymphocytic leukemia.Proc Am Assoc Cancer Res\n                  16, 232 (1975).","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF02934855_CR2","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/S0140-6736(80)92664-1","volume":"1","author":"D M Green","year":"1980","unstructured":"Green D M, Freeman A I, Sather H N, Sallan S E, Nesbit M E, Cassady T R, Sinks L F, Hammond D, Frei E: Comparison of three methods of CNS prophylaxis in childhood acute lymphoblastic leukemia.Lancet\n                  1, 1398 (1980).","journal-title":"Lancet"},{"key":"BF02934855_CR3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00257189","volume":"2","author":"M Bayssas","year":"1979","unstructured":"Bayssas M, Gouvera J, Ribaud P, Masset M, De Vassal F, Pico J L, Deluca L, Misset J L, Machover D, Belpomme D, Schwarzenberg L, Jasmin C, Hayat M, Mathe G: Phase II trial of vindesine for regression. Induction in patients with leukemias and hematosarcomas.Cancer Chemother Pharmac\n                  2, 247 (1979).","journal-title":"Cancer Chemother Pharmac"},{"key":"BF02934855_CR4","first-page":"1049","volume":"65","author":"P L Chello","year":"1981","unstructured":"Chello P L, Sirotnak F M: Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L 1210 leukemia.Cancer Treatment Rep\n                  65, 1049 (1981).","journal-title":"Cancer Treatment Rep"},{"key":"BF02934855_CR5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00262421","volume":"3","author":"S Monjanel","year":"1979","unstructured":"Monjanel S, Rigault J P, Cano J P, Carcassonne Y, Favre R: High dose methotrexate: preliminary evaluation of a pharmacokinetic approach.Cancer Chemother Pharmac\n                  3, 189 (1979).","journal-title":"Cancer Chemother Pharmac"},{"key":"BF02934855_CR6","first-page":"297","volume":"10","author":"J R Bertino","year":"1964","unstructured":"Bertino J R, Fischer G A: Technics for study of resistance to folic acid antagonists.Methods Med Res\n                  10, 297 (1964).","journal-title":"Methods Med Res"},{"key":"BF02934855_CR7","unstructured":"Root M A, Gerzon K, Dyke R W: Radio immunoassay for vinblastine and vincristine. Abst. 183. Fed. Anal Chem. Spectrosc. Soc. Meeting. October, Indianapolis (1975)."},{"key":"BF02934855_CR8","first-page":"1326","volume":"2","author":"C Tan","year":"1978","unstructured":"Tan C: Clinical and pharmacokinetic studies of vindesine in 50 children with malignant diseases.Proc 10th Int Congr Chemother, Washington2, 1326 (1978).","journal-title":"Proc 10th Int Congr Chemother, Washington"},{"key":"BF02934855_CR9","first-page":"276","volume":"36","author":"I D Goldman","year":"1976","unstructured":"Goldman I D, Gupta V, White J C: Exchangeable intra-cellular methotrexate levels in the presence and absence of vincristine at extracellular drug concentrations relevant to those achieved in high dose methotrexate folinic acid rescue protocols.Cancer Res\n                  36, 276 (1976).","journal-title":"Cancer Res"},{"key":"BF02934855_CR10","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1016\/S0021-9258(19)43672-7","volume":"248","author":"M J Fyle","year":"1973","unstructured":"Fyle M J, Goldman I D: Characteristics of the vincristine-induced augmentation of methotrexate uptake in ehrlich ascites tumor cells.J Biol Chem\n                  248, 5067 (1973).","journal-title":"J Biol Chem"},{"key":"BF02934855_CR11","first-page":"143","volume":"63","author":"F Tejada","year":"1979","unstructured":"Tejada F, Zubrod C G: Vincristine effect on methotrexate cerebrospinal fluid concentration.Cancer Treatment Rep\n                  63, 143 (1979).","journal-title":"Cancer Treatment Rep"},{"key":"BF02934855_CR12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00254603","volume":"12","author":"N Lena","year":"1984","unstructured":"Lena N, Imbert A M, Pignon T, Favre R, Meyer G, Cano J P, Carcassonne Y: Methotrexate-vindesine association in the treatment of head and neck cancer. Influence of vindesine on methotrexate\u2019s pharmacokinetic behavior.Cancer Chemother Pharmac\n                  12, 120 (1984).","journal-title":"Cancer Chemother Pharmac"}],"container-title":["Medical Oncology and Tumor Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02934855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02934855\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02934855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T18:58:26Z","timestamp":1631905106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02934855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,6]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,6]]}},"alternative-id":["BF02934855"],"URL":"https:\/\/doi.org\/10.1007\/bf02934855","relation":{},"ISSN":["0736-0118"],"issn-type":[{"value":"0736-0118","type":"print"}],"subject":[],"published":{"date-parts":[[1985,6]]}}}